Grant funding uncertainty has jeopardized the sustainability of research projects and discouraged researchers.
Last year, the path to FDA authorization of the psychedelic drug MDMA for treatment of PTSD hit an unexpected snag. It later ...
Jim Jones, deputy commissioner for human foods at the U.S. Food and Drug Administration (FDA), resigned yesterday.
"The whole COVID discussion turned into culture war dialogue, with one side saying, 'I believe in the economy and liberty,' ...
Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.
A new research paper was published in Oncotarget, Volume 16, on February 18, 2025, titled “Robust p53 phenotypes and ...
About 4 million American adults have the chronic condition. Treatment may include a combination of painkillers, cognitive ...
After NIH-funded studies linked untreated hearing loss to health issues such as dementia, Hopkins professor Frank Lin ...
With the confirmation of Robert F. Kennedy Jr. as secretary of Health and Human Services, as well as Brooke Rollins as secretary of the Department ...
Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a ...
News Medical on MSN1d
Study finds key p53 targets for future cancer treatmentA new research paper was published in , Volume 16, on February 18, 2025, titled "Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback